Daicel Corporation

4202.T
Specialty Chemicals
2026/08/03 Updated
Market Cap: $2.3B (¥370.4B)
Stock Price: $9.18 (¥1,451)
Exchange Rate: 1 USD = ¥157.98

Fiscal Year 2027 Q1 Financial Results|Net Sales of ¥152.4 billion (YoY +9.4%)

Daicel achieved net sales of ¥152.4 billion (YoY +9.4%) and operating income of ¥14.0 billion (+7.7%) in the first quarter of fiscal year 2027. Segment-wise, the high-performance materials and materials businesses performed well, supporting overall sales and profits.

Importance:
Page Updated: July 31, 2026
IR Disclosure Date: July 31, 2026

Key Figures

  • Net Sales: ¥152.4 billion (YoY +9.4%)
  • Operating Income: ¥14.0 billion (YoY +7.7%)
  • Net Income: ¥9.4 billion (YoY △2.7%)

AI要約

Performance Overview

Future Outlook and Investor Impact

Daicel continues to aim for expansion in its high-performance materials and materials businesses, promoting growth strategies. It anticipates steady performance and long-term growth. For investors, consistent results and prospects for future expansion are key points. In particular, increasing demand for high-performance materials and strengthening overseas activities are expected to drive medium- to long-term stock price growth.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

Daicel Corporation

Company overview · Stock price · Financial data · All IR

View company page →